Kelly Knight, PhD

Associate Professor

Research Interests: The social construction and experience of addiction; Co-morbidity (HIV, substance abuse, mental illness), homelessness, and US urban health; Chronic non-cancer pain, clinical uncertainty, and scientific evidence; Post-traumatic stress disorder (PTSD), bi-polar disorder, and the US welfare state; Gender, reproduction, motherhood and citizenship.
Education
2017 - Diversity, Equity, and Inclusion Champion Training, University of California
PhD, 2010 - Graduate Division (Medical Anthropology), University of California, San Francisco
EdM, 1993 - Human Development and Psychology, Harvard University
BA, 1991 - Philosophy, Psychology, Theology, Georgetown University
Honors and Awards
  • Bridges Curriculum Teaching Award: Excellence in Innovative Teaching Modalities, UCSF School of Medicine, 2018
  • Foundation for the Sociology of Health and Illness Book Award, British Sociological Association, 2016
  • Honorable Mention, Eileen Basker Memorial Prize, Society for Medical Anthropology, 2016
  • Finalist (5/94), C. Wright Mills Award, Society for the Study of Social Problems, 2015
  • Chancellor’s Graduate Research Fellowship, UCSF, 2008
Websites
Publications
  1. Reproductive (In)justice - Two Patients with Avoidable Poor Reproductive Outcomes.
  2. Vulnerable Patients' Psychosocial Experiences in a Group-Based, Integrative Pain Management Program.
  3. Sources and Impact of Time Pressure on Opioid Management in the Safety-Net.
  4. Patients' and clinicians' perspectives of co-use of cannabis and opioids for chronic non-cancer pain management in primary care.
  5. Women on the edge: opioids, benzodiazepines and the social anxieties surrounding women’s reproduction in the US opioid epidemic
  6. Women on the Edge: Opioids, Benzodiazepines, and the Social Anxieties Surrounding Women's Reproduction in the U.S. "Opioid Epidemic".
  7. Opioid pharmacovigilance: A clinical-social history of the changes in opioid prescribing for patients with co-occurring chronic non-cancer pain and substance use.
  8. The risks of opioid treatment: Perspectives of primary care practitioners and patients from safety-net clinics.
  9. Teaching Structure: A Qualitative Evaluation of a Structural Competency Training for Resident Physicians.
  10. Provider Experiences With the Identification, Management, and Treatment of Co-occurring Chronic Noncancer Pain and Substance Use in the Safety Net.
  11. Primary care providers' experiences with urine toxicology tests to manage prescription opioid misuse and substance use among chronic noncancer pain patients in safety net health care settings.
  12. addicted.pregnant.poor. Duke University Press
  13. Risk factors for stimulant use among homeless and unstably housed adult women.
  14. Syndemic vulnerability, sexual and injection risk behaviors, and HIV continuum of care outcomes in HIV-positive injection drug users.
  15. Recent violence in a community-based sample of homeless and unstably housed women with high levels of psychiatric comorbidity.
  16. A roadmap for adapting an evidence-based HIV prevention intervention: personal cognitive counseling (PCC) for episodic substance-using men who have sex with men.
  17. Single room occupancy (SRO) hotels as mental health risk environments among impoverished women: the intersection of policy, drug use, trauma, and urban space.
  18. Agents of change: peer mentorship as HIV prevention among HIV-positive injection drug users.
  19. San Francisco and the Biomedicalization of Poverty
  20. The public life of sex work: risk, politics, and public health
  21. HIV intervention for providers study: a randomized controlled trial of a clinician-delivered HIV risk-reduction intervention for HIV-positive people.
  22. Predictors of sharing injection equipment by HIV-seropositive injection drug users.
  23. Predictors of current housing status among HIV-seropositive injection drug users (IDUs): results from a 1-year study.
  24. Factors associated with antiretroviral therapy adherence and medication errors among HIV-infected injection drug users.
  25. Intimate partner violence perpetration against main female partners among HIV-positive male injection drug users.
  26. Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users.
  27. Sexual transmission risk behavior reported among behaviorally bisexual HIV-positive injection drug-using men.
  28. Unprotected sexual behavior among heterosexual HIV-positive injection drug using men: associations by partner type and partner serostatus.
  29. Split Ends: Masculinity, sexuality and emotional intimacy among HIV-positive heterosexual men. Men and Masculinities 8:309-320
  30. "You cannot do nothing in this damn place": sex and intimacy among couples with an incarcerated male partner.
  31. Sexual risk taking among HIV-positive injection drug users: contexts, characteristics, and implications for prevention.
  32. The Health Care Experience of HIV Positive Injection Drug Users. Journal of Multicultural Nursing and Health, 11(1): 23-30
  33. With a little help from my friends: community affiliation and social support among HIV-positive gay and bisexual men
  34. The life priorities of HIV-seropositive injection drug users: findings from a community-based sample.
  35. Drug users talk about HIV testing: motivating and deterring factors.
  36. "I don't know when it might pop up": understanding repeat HIV testing and perceptions of HIV among drug users.
  37. Voices from the field: providers discuss HIV counseling and testing programs for drug users.
  38. This is my story: a descriptive analysis of a peer education HIV/STD risk reduction program for women living in housing developments.
  39. Managing HIV among serodiscordant heterosexual couples: serostatus, stigma and sex.
  40. Defunding the poor: the impact of lost access to subsidized methadone maintenance treatment on women injection drug users. Journal of Drug Issues. 26(4): 923-942
  41. Involuntary verses voluntary detoxification from methadone maintenance treatment: the importance of choice. Addiction Research 3(4): 351-362
  42. Methadone maintenance: treatment as harm reduction, defunding as harm maximization. Journal of Psychoactive Drugs 28(3)
  43. Violence: a barrier to methadone maintenance treatment for women injection drug users. International Journal of Sociology and Social Policy 16(5): 143-164